[go: up one dir, main page]

EP0551308A4 - Novel peptide antigens and immunoassays, test kits and vaccines using the same - Google Patents

Novel peptide antigens and immunoassays, test kits and vaccines using the same

Info

Publication number
EP0551308A4
EP0551308A4 EP9191916706A EP91916706A EP0551308A4 EP 0551308 A4 EP0551308 A4 EP 0551308A4 EP 9191916706 A EP9191916706 A EP 9191916706A EP 91916706 A EP91916706 A EP 91916706A EP 0551308 A4 EP0551308 A4 EP 0551308A4
Authority
EP
European Patent Office
Prior art keywords
immunoassays
vaccines
same
test kits
peptide antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP9191916706A
Other versions
EP0551308A1 (en
Inventor
Renu Bansal Lal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Commerce
US Department of Health and Human Services
Original Assignee
United States Department of Commerce
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/574,352 external-priority patent/US5378805A/en
Application filed by United States Department of Commerce, US Department of Health and Human Services filed Critical United States Department of Commerce
Publication of EP0551308A1 publication Critical patent/EP0551308A1/en
Publication of EP0551308A4 publication Critical patent/EP0551308A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP9191916706A 1990-08-29 1991-08-29 Novel peptide antigens and immunoassays, test kits and vaccines using the same Withdrawn EP0551308A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/574,352 US5378805A (en) 1990-08-29 1990-08-29 Immunoreactive HTLV-I/II ENV and POL peptides
US574352 1990-08-29
US73477791A 1991-07-23 1991-07-23
US734777 1991-07-23

Publications (2)

Publication Number Publication Date
EP0551308A1 EP0551308A1 (en) 1993-07-21
EP0551308A4 true EP0551308A4 (en) 1994-09-14

Family

ID=27076368

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9191916706A Withdrawn EP0551308A4 (en) 1990-08-29 1991-08-29 Novel peptide antigens and immunoassays, test kits and vaccines using the same

Country Status (5)

Country Link
EP (1) EP0551308A4 (en)
JP (1) JPH07502483A (en)
AU (1) AU641554B2 (en)
CA (1) CA2090470A1 (en)
WO (1) WO1992004046A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0643835B1 (en) * 1992-02-24 2001-04-18 Genelabs Technologies, Inc. Htlv-i/htlv-ii assay and method
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
ATE384795T1 (en) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic MODIFIED HIV ENV POLYPEPTIDES
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1141313A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP3502272A1 (en) * 2010-06-21 2019-06-26 Life Technologies Corporation Compositions, kits, and methods for synthesis and/or detection of nucleic acids

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008162A1 (en) * 1989-01-13 1990-07-26 United Biomedical Inc. Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1
WO1990010231A1 (en) * 1989-03-02 1990-09-07 Replico Medical Ab Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits
WO1990015820A1 (en) * 1989-06-13 1990-12-27 Syntello Ab Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
EP0439077A2 (en) * 1990-01-24 1991-07-31 United Biomedical Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02209889A (en) * 1988-02-08 1990-08-21 Univ Duke Synthetic hydrophilic peptide
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
JPH03107764A (en) * 1989-09-21 1991-05-08 Nippon Sekijiyuujishiya Method for measuring antibody associated with adult type t cellular leukemia
JP2807287B2 (en) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 Peptides and their uses
EP0424748B1 (en) * 1989-10-23 1995-05-10 F. Hoffmann-La Roche Ag Synthetic envelope peptides of HTLV-I

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008162A1 (en) * 1989-01-13 1990-07-26 United Biomedical Inc. Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1
WO1990010231A1 (en) * 1989-03-02 1990-09-07 Replico Medical Ab Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits
WO1990015820A1 (en) * 1989-06-13 1990-12-27 Syntello Ab Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
EP0439077A2 (en) * 1990-01-24 1991-07-31 United Biomedical Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9204046A1 *

Also Published As

Publication number Publication date
EP0551308A1 (en) 1993-07-21
WO1992004046A1 (en) 1992-03-19
JPH07502483A (en) 1995-03-16
AU641554B2 (en) 1993-09-23
AU8610091A (en) 1992-03-30
CA2090470A1 (en) 1992-03-01

Similar Documents

Publication Publication Date Title
GB9012995D0 (en) Multivalent antigen-binding proteins
FI923839A7 (en) Collection from the mouth for immunological testing
NO915137D0 (en) Hitherto unknown antibodies that are reactive with human carcinomas
FI914908A0 (en) NY MONOCLONAL ANTIKROPP MED NY ANTIGEN RELATERAD TILL HUMANA TUMOERER.
HUT66753A (en) Novel antibodies and methods for their use
NO924279D0 (en) LYOPHILIZED, MONOCLONAL ANTIBODY PREPARATION
AU2843889A (en) Antigen antibody conjugate
IL98769A0 (en) Synthetic peptides,mixtures thereof and methods utilizing the same for detecting hiv antibodies
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
EP0555418A4 (en) Peptide binding assays with mhc antigens
AU2412692A (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
GR880100180A (en) Test for the hepatite antigens and aids antigens detection
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
EP0500826A4 (en) Apo ai polypeptides, antibodies, and immunoassays
NZ223624A (en) Peptide immunogen from streptococcus mutans, vaccines and antibodies
IL95999A0 (en) Tumor-associated antigen
IL94304A0 (en) Novel tumor-associated antigen,antibodies,compositions and uses therefor
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
GB2267148B (en) Footrot antigens,vaccines and diagnostic assays
GB9021286D0 (en) Antigens and antibodies thereto their uses
AU2624288A (en) Hiv peptides, artificial hiv antigens and immunoassay kits
AU640398B2 (en) Antigens and polypeptides derived from babesia (12d3 antigen)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C07K 7/10

A4 Supplementary search report drawn up and despatched

Effective date: 19940728

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19951031